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Reference Chart Derived From Post–Stent-Implantation
Intravascular Ultrasound Predictors of 6-Month Expected
Restenosis on Quantitative Coronary Angiography
P.J. de Feyter, MD, PhD; P. Kay, MD; C. Disco, MSC; P.W. Serruys, MD, PhD
Background—Intravascular ultrasound (IVUS)–guided stent implantation and the availability of a reference chart to
predict the expected in-stent restenosis rate based on operator-dependent IVUS parameters may interactively facilitate
optimal stent placement. The use of IVUS guidance protects against undue risks of dissection or rupture.
Methods and Results—IVUS-determined post–stent-implantation predictors of 6-month in-stent restenosis on quantitative
coronary angiography (QCA) were identified by logistic regression analysis. These predictors were used to construct a
reference chart that predicts the expected 6-month QCA restenosis rate. IVUS and QCA data were obtained from 3
registries (MUSIC [Multicenter Ultrasound Stenting in Coronaries study], WEST-II [West European Stent Trial II], and
ESSEX [European Scimed Stent EXperience]) and 2 randomized in-stent restenosis trials (ERASER [Evaluation of
ReoPro And Stenting to Eliminate Restenosis] and TRAPIST [TRApidil vs placebo to Prevent In-STent intimal
hyperplasia]). In-stent restenosis was defined as luminal diameter stenosis .50% by QCA. IVUS predictors were
minimum and mean in-stent area, stent length, and in-stent diameter. Multiple models were constructed with
multivariate logistic regression analysis. The model containing minimum in-stent area and stent length best fit the
Hosmer-Lemeshow goodness-of-fit test. This model was used to construct a reference chart to calculate the expected
6-month restenosis rate.
Conclusions—The expected 6-month in-stent restenosis rate after stent implantation for short lesions in relatively large
vessels can be predicted by use of in-stent minimal area (which is inversely related to restenosis) and stent length (which
is directly related to restenosis), both of which can be read from a simple reference chart. (Circulation.
1999;100:1777-1783.)
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Intracoronary stent implantation has unequivocally beenshown to reduce the frequency of 6-month in-stent reste-
nosis in focal lesions in relatively large coronary vessels.1–4
Intravascular ultrasound (IVUS) has successfully been used
to guide stent implantation and often results in a wider stented
lumen, which may, according to the “bigger is better”
principle, further reduce the restenosis rate.5–21 In the present
study, we sought to identify post–stent-implantation IVUS
predictors of in-stent restenosis. These parameters are partly
operator dependent and are available online; thus, they can be
adjusted by the operator during actual stent implantation to
achieve the best possible result.
We performed a meta-analysis to determine final post–
stent-implantation IVUS predictors of 6-month restenosis
(diameter stenosis $50%) by quantitative coronary angiog-
raphy (QCA) after stent implantation in focal lesions and
large vessels. Patients were selected from 3 stent registries
(MUSIC [Multicenter Ultrasound Stenting in Coronaries
study],14 WEST-II [West European Stent Trial II],22 and
ESSEX [European Scimed Stent EXperience]) and from 2
randomized trials investigating the efficacy of a pharmaceu-
tical agent on in-stent restenosis (ERASER [Evaluation of
ReoPro And Stenting to Eliminate Restenosis] and TRAPIST
[TRApidil vs placebo to Prevent In-STent intimal hyperpla-
sia]). The latter 2 trials did not demonstrate a significant
difference between drugs and placebo, and thus for the
present study, all patients groups were combined. The regis-
tries and trials have been considered together because the
IVUS and QCA analyses used were performed in the same
core laboratory.
The analysis was performed by a multistep approach. First,
IVUS predictors for 6-month in-stent (QCA) restenosis were
identified. Second, various univariate and multivariate mod-
els were constructed with these parameters to predict the
observed restenosis. Third, models were selected that had the
best fit on the Hosmer-Lemeshow goodness-of-fit test. Fi-
nally, from the best-fit models, the model with the most easily
obtainable and clinically relevant parameters was selected,
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and a reference chart was constructed that predicted the
expected angiographic in-stent restenosis rate after stent
implantation of short lesions in relative large vessels.
Methods
Patients were selected from 3 stent registries and 2 randomized
restenosis trials (Table 1). Only patients who underwent single-
lesion treatment were enrolled. Various stent types were implanted:
2 balloon-expandable stents (15-mm Palmaz-Schatz, Cordis Corp;
and 15-mm Multi-Link, Guidant/Advanced Cardiovascular Systems)
and 2 self-expanding stents (14-mm Radius, Scimed Life Systems;
and the Wallstent, Schneider Europe [various stent lengths]) were
used. All registries and trials used intracoronary ultrasound as
guidance for optimal stent implantation. Patients were included in
the present study if they had both an adequate final post–stent-
implantation IVUS examination and a 6-month coronary angiogram
to establish the restenosis rate. Six-month in-stent restenosis was
determined with QCA and was defined as an in-stent luminal
diameter stenosis $50%. The restenosis rate in the above-mentioned
studies varied from 9.8% to 25.7%.
Baseline clinical characteristics are shown in Table 2. Overall,
there were only small differences between the various patient groups
except for the severity of angina, which was less severe in the
WEST-II and ESSEX registries, and the higher frequency of prior
myocardial infarction in the ERASER and TRAPIST randomized
trials.
Intravascular Ultrasound
Three different intracoronary ultrasound imaging devices were used.
The CVIS (Microview) has a 30-MHz single-element bevelled
transducer mounted on the end of a flexible shaft that rotates at 1800
rpm within either a 2.9F echotransparent long-monorail/common-
distal-lumen imaging sheath or within a 3.2F short-monorail imaging
sheath. The Hewlett-Packard/Boston Scientific Corp device incorpo-
rates a single-element 30-MHz bevelled monorail transducer that
rotates at 1800 rpm within a 3.5F short-monorail imaging catheter.
The Endosonics Europe device consists of 64 elements mounted at
the tip, and the coaxial catheter allows either a monorail or an
over-the-wire technique to be used.
IVUS imaging was performed during a motorized uniform pull-
back speed of 0.5 mm/s in all patients. The video signal was recorded
on a high-resolution super-VHS tape. The videotape was used to
obtain manual online in-stent IVUS measurements to guide stent
implantation. In-stent diameter (mm), in-stent minimum area (mm2),
and lumen measurements at the 3- to 5-mm reference area proximal
and distal to the stented segment were obtained. Stent apposition to
the vessel wall and symmetrical stent expansion were reviewed over
the entire stented segment. Optimal IVUS-guided stent implantation
was attempted with the MUSIC criteria (complete stent apposition,
symmetrical expansion, and adequate in-stent cross-sectional area),
but it was left to the discretion of the operator to stop further attempts
to achieve these criteria if additional dilation might pose a significant
risk of dissection or rupture.14
Quantitative IVUS Measurements
A Microsoft Windows-based contour-detection program was used
for automated 3D analysis of IVUS images. The contour-detection
program was performed in 2 steps. First, 2 longitudinal sections were
constructed from the 3D data set, and an automated contour-
detection algorithm determined lumen-intima and media-adventitia
boundaries of nonstented segments and lumen-stent boundary in
stented segments. The contour-detection program uses a minimum-
cost–based algorithm. These longitudinal contours were used to
define regions of interest in the individual cross-sectional IVUS
images. Next, the regions of interest were used to guide the
second-final automated contour detection in these cross sections. A
cursor on the longitudinal sections indicated the individual cross
sections and allowed scrolling through the entire cross-sectional data
set, to allow the technician to assess the automatically detected
TABLE 1. Features of In-Stent Restenosis Registries and Randomized Trials
Trial Stent
Patients
Recruited
in Study, n
Patients With
IVUS at
Baseline, n
Study Patients With
IVUS at Baseline
and QCA at
Follow-Up, n Type of Study
IVUS-Guided
Stenting
Restenosis by
QCA, %
Balloon-expandable stents
MUSIC P-S (15 mm) 161 151 140 Registry Yes 9.8
WEST-II Multi-Link (15 mm) 165 151 137 Registry Yes 11.7
ERASER P-S (15 mm) 215 190 162 Randomized Yes 19.8
Self-expanding stents
ESSEX Radius (14 mm) 103 92 89 Registry Yes 21.3
TRAPIST Wallstent (29 mm) 312 274 245 Randomized Yes 25.7
Total 956 858 773
P-S indicates Palmaz-Schatz.
TABLE 2. Baseline Clinical Characteristics
MUSIC
(n5151)
WEST-II
(n5151)
ERASER
(n5190)
ESSEX
(n592)
TRAPIST
(n5274)
Age, y 60610 60610 6069 6269 6069
Male sex, % 82 78 79 84 81
CCS III/IV, % 43 23 55 18 51
Diabetes mellitus, % 11 15 14 12 14
Prior MI, % 25 22 43 24 46
Prior CABG, % 2 4 7 3 5
Prior PTCA, % 9 12 13 25 17
CCS indicates Canadian classification angina; MI, myocardial infarction.
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contours. These user-interactive adjustments were made by “forcing”
the contour through visually identified contour points, which then
resulted in an upgrading of the entire data set (dynamic
programming).
The automatic contour program allows for automated analysis of
a maximum of 200 cross sections. The distance between 2 cross
sections (slice thickness) therefore depends on the length of the
segment of interest, with a minimum of 0.2 mm and a maximum of
0.5 mm.
In-stent IVUS measurements were as follows: in-stent minimum
and mean diameter, in-stent mean and minimum area, stent volume,
and stent length. Reference area measurements were the mean of the
lumen area of the proximal and distal 5 mm of coronary lumen
adjacent to the stent.
Volumes of total stent were calculated as
V5O
i51
n
AizH
where V is volume, A is cross-sectional area of stent, H is thickness
of the coronary slice, and n is the number of digitized cross sections
encompassing the index volume. In-stent length was calculated as
the number of images analyzed multiplied by the distance between 2
adjacent images.
The intraobserver and interobserver variabilities were ,1.0%, and
the SD of differences varied between 4% and 9.5%.16,17
Quantitative Coronary Angiography
The minimal in-stent lumen diameter was determined on an end-di-
astolic frame by use of a computer-based Coronary Angiography
Analysis System (CAAS II: Pie Medical). The edge-detection
algorithm is based on the weighted sum of the first- and second-
derivative functions applied to the digitized brightness silhouette.23
The diameter function of the coronary artery lumen was deter-
mined by computing the shortest distance between the edge points of
the right and left boundaries. The minimum lumen diameter was
defined as the shortest distance between all measured left and right
boundaries. The interpolated diameter was based on a computer
estimation of the original lumen diameter, determined at the site of
the minimum lumen diameter by taking into account the diameter
function of the proximal and distal references. The diameter stenosis
was derived from the measured minimum lumen diameter and the
interpolated reference diameter.
Statistical Analysis
Statistical analysis was performed with SAS version 6.12. Quantitative
data are given as mean6SD and qualitative data as frequencies.
IVUS parameters concerning volumetric measurements were not
available in '67% of the patients selected from the MUSIC trial
because a manual IVUS pullback was performed. Multiple IVUS
parameters were tested by univariate logistic regression analysis to
determine 6-month QCA restenosis predictors. With multivariate
logistic regression analysis, multiple models containing IVUS pa-
rameters predictive of 6-month restenosis were constructed. These
models were then tested by use of the Hosmer-Lemeshow goodness-
of-fit test to choose the most appropriate model. In the Hosmer-
Lemeshow goodness-of-fit test, an estimated event probability is
calculated from the observations by use of a model. These observa-
tions are then sorted in order of their estimated event probability and
divided into '10 groups (g) of approximately equal size. The
Hosmer-Lemeshow goodness-of-fit statistic is obtained by calculat-
ing the Pearson x2 test from the 23g table of the observed and
expected frequencies. The greater the P value, the better the model
fits the data.
Results
The final post–stent-implantation IVUS measurements that
were obtained in the various studies are tabulated in Table 3.
In the MUSIC registry, the largest minimal in-stent cross-
sectional area was achieved. The length of the implanted stent
was longer, and consequently the in-stent volume was higher
in the TRAPIST trial, which used Wallstents. The reference
vessel diameter was smallest in the ESSEX registry. Univar-
iate analysis of postprocedure final IVUS parameters showed
that type of stent and all dimensional in-stent parameters
except in-stent volume were significant predictors of reste-
nosis (Table 4).
Multiple models were constructed with the IVUS parame-
ters in univariate and multivariate analyses. When the
Hosmer-Lemeshow goodness-of-fit test was used, 4 poten-
tially appropriate models emerged (Table 5). One model was
based on 1 parameter only (minimum in-stent area); the other
3 models were based on 2 parameters, and all 3 used stent
length in combination with stent volume, mean stent area, or
minimum stent area. Addition of any third parameter to a
model did not significantly improve the predictive power.
The combination of stent length and minimum in-stent area
was chosen as the most easily obtainable and clinically
TABLE 3. Final IVUS Measurements After Stent Implantation
MUSIC
(n5151)
WEST-II
(n5151)
ERASER
(n5190)
ESSEX
(n592)
TRAPIST
(n5274)
Minimum in-stent area, mm2 7.8562.0 7.3961.9 7.0462.0 6.9662.0 6.1761.9
Projected minimum lumen diameter, mm 2.7760.4 2.7860.4 2.6760.4 2.6760.4 2.5960.4
Mean in-stent area, mm2 9.4562.4 8.9562.2 8.7162.3 8.5362.3 7.8362.1
Stent volume, mm3 NA 154675 1686113 128658 2276131
Stent length, mm NA* 17.166.6 19.5611.9 14.864.2 28.6613.2
Mean reference lumen area, mm2 9.4562.5 9.5963.1 9.063.3 8.7262.9 9.3464.1
NA indicates not available in all patients.
*The length of the stent was 15.262.0, which was obtained from angiographic data.
TABLE 4. IVUS Parameters After the Procedure: Univariate
Analysis of Predictors of Restenosis Rate
Parameter P
Minimum in-stent area ,0.001
Projected minimum lumen diameter ,0.001
Mean in-stent area ,0.001
Stent volume 0.174
Stent length ,0.001
Mean reference lumen area 0.020
Type of stent (Palmaz-Schatz, Radius, Multi-Link, Wallstent) 0.014
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relevant parameters. The observed and expected restenosis
rates of this model are depicted in Figure 1. The model
remained accurate after the same analysis was performed
with exclusion of Wallstent patients (who are known to have
a higher restenosis rate), but the CIs were wider.
Next, a reference chart was developed (Table 6 and Figure
2) that can be used as a ready reference to estimate the
expected in-stent restenosis rate with stent length and post–
stent-implantation minimal in-stent area. The ranges of the 2
variables were divided into 10 groups each. The expected
restenosis rate for the median of each range was calculated
along with the 95% CIs for that particular value. The
expected restenosis rate is given, as well as the CI.
The majority of observations were clustered around 15-
mm-length stents and a minimum in-stent area of 8 mm2
(Figure 3). Values in Table 6 that are marked by asterisks
were calculated by extrapolation from the model because
there were no actual observations in that range. The reference
chart in these ranges should be used with caution.
Discussion
In-stent restenosis remains a significant clinical problem
because it is difficult to treat. IVUS-guided stent implantation
has optimized stent expansion, and the initial higher lumen
area achieved has been associated with a lower 6-month
restenosis rate.14,18 We reasoned that construction of a refer-
ence chart based on simple, easily obtainable, clinically
relevant IVUS post–stent-implantation parameters that pre-
dicts the expected 6-month restenosis rate would be clinically
useful. First, online knowledge of an expected restenosis rate
based on IVUS-determined post–stent-implantation lumen
dimensions and stent length obtained while the procedure is
being performed may serve as an extra stimulus to attempt to
achieve the best possible result of stent implantation, whereas
IVUS guidance may reduce the undue risks of dissection or
vessel rupture.12 Second, a priori knowledge of the expected
restenosis rate based on the lesion length and vessel size,
which are decisive in stent size and length selection, may be
useful in counseling patients whether to select a percutaneous
intervention or bypass surgery. Third, it may be helpful to
discuss the probability of restenosis after stent implantation
and accordingly plan closer monitoring of patients. Fourth,
the reference chart may be helpful to plan and power future
in-stent restenosis studies.
IVUS variables, including in-stent area, extent of preexist-
ing plaque, smaller vessel size, stenting of total occlusions,
and history of diabetes mellitus, as well as implantation of a
long stent, have been shown to predict in-stent resteno-
sis.10,20,21,24–26 In the present study, we found that 2 IVUS
variables (minimum in-stent area and stent length) were
strong predictors of 6-month restenosis. Using these 2 vari-
ables, it was possible for us to construct a reference chart that
predicts the 6-month expected restenosis rate. Basically, the
chart demonstrates that the widest in-stent area has the lowest
restenosis rate, and the longer the implanted stent, the higher
the restenosis rate. The achievement of maximal in-stent
TABLE 5. Models (Univariate and Multivariate) Used to Predict
Expected 6-Month QCA In-Stent Restenosis
Parameter Coefficient SE P
Hosmer-Lemeshow
Goodness-of-Fit
Statistic (P)
Intercept 0.664 z z z z z z z z z
Minimum in-stent area 20.325 0.06 ,0.001 z z z
7.60 (0.47)
Intercept 22.136 z z z z z z z z z
Stent volume 20.011 0.002 ,0.001 z z z
Stent length 0.119 0.019 ,0.001 z z z
7.60 (0.47)
Intercept 0.009 z z z z z z z z z
Mean in-stent area 20.264 0.054 ,0.001 z z z
Stent length 0.031 0.008 ,0.001 z z z
6.41 (0.60)
Intercept 20.199 z z z z z z z z z
Minimum in-stent area 20.285 0.060 ,0.001 z z z
Stent length 0.028 0.007 ,0.001 z z z
8.11 (0.42)
Figure 1. Reliability of model comparing
observed vs expected 6-month restenosis
rate (y axis) in various Hosmer-Lemeshow
groups (x axis). Ideally, the observed and
expected restenosis rates should be
identical.
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dimensions expressed in terms of diameter, area, or volume is
in keeping with the “bigger is better” theory and thus is
associated with a lesser likelihood of reaching the expected
restenosis rate.8,10,13,20,27,28
The inverse relation of stent length and 6-month restenosis
may be explained by the purely statistical fact that a longer
stent has a higher chance of restenosis. However, a preexist-
ing longer lesion, known to be associated with a higher
restenosis rate, may be responsible. The inverse relation
between stent length and restenosis may be taken as an
argument for choosing a conservative stent-length implanta-
tion approach or “spot” stenting, but the efficacy of this
approach should be tested in an appropriate randomized trial.
In the individual studies (Table 1), the restenosis rate was
higher in self-expanding stents than balloon-expandable
stents, which suggests that the stent design may be associated
with differences in restenosis rates. However, in the multi-
variate analysis, once we used the parameters of stent length
and an area or volume measurement, stent design did not
retain significance. It has been suggested that Wallstent
implantation confers a higher restenosis rate. Therefore, we
performed an analysis excluding Wallstent patients. The
model was still accurate, but because of the lesser number of
observations, it obviously is less reliable, with wider CIs.
We selected QCA at 6 months as our restenosis end point
because the angiographic criterion of .50% diameter steno-
sis is a generally accepted criterion and can also be used, in
contrast to IVUS-obtained restenosis parameters, in case of
severe in-stent restenosis or a totally occluded stent.29
Figure 2. Three-dimensional representation of restenosis rate
(y axis) in relation to minimum in-stent area (x axis) and stent
length (z axis).
Figure 3. Frequency distribution of number of observations
(y axis) according to minimum in-stent area (x axis) and stent
length (z axis).
TABLE 6. Reference Chart
Stent
Length,
mm
Minimum In-Stent Area, mm2
3.0–3.9 3.9–4.8 4.8–5.7 5.7–6.6 6.6–7.5 7.5–8.4 8.4–9.3 9.3–10.2 10.2–11.1 11.1–12.0
10–15 0.30 0.25 0.21 0.17 0.13 0.11 0.08 0.07 0.05 0.04
(0.22–0.40) (0.19–0.32) (0.16–0.26) (0.13–0.21) (0.11–0.17) (0.08–0.14) (0.06–0.12) (0.04–0.10) (0.03–0.09) (0.02–0.08)
15–20 0.33 0.28 0.23 0.19 0.15 0.12 0.10 0.08 0.06 0.05
(0.25–0.42) (0.22–0.34) (0.19–0.28) (0.16–0.22) (0.12–0.18) (0.09–0.16) (0.07–0.13) (0.05–0.12) (0.04–0.10) (0.02–0.09)
20–25 0.36 0.31 0.25 0.21 0.17 0.14 0.11 0.09 0.07 0.05*
(0.28–0.46) (0.25–0.37) (0.21–0.30) (0.18–0.24) (0.14–0.20) (0.11–0.17) (0.09–0.15) (0.06–0.13) (0.04–0.11) (0.03–0.10)
25–30 0.40 0.34 0.28 0.23 0.19 0.15 0.12 0.10 0.08 0.06
(0.31–0.49) (0.27–0.41) (0.24–0.33) (0.20–0.27) (0.16–0.23) (0.12–0.20) (0.09–0.17) (0.06–0.15) (0.05–0.13) (0.03–0.11)
30–35 0.43 0.37 0.31 0.26 0.21 0.17 0.14 0.11 0.09* 0.07*
(0.34–0.53) (0.30–0.44) (0.26–0.38) (0.22–0.31) (0.17–0.26) (0.13–0.22) (0.10–0.19) (0.07–0.17) (0.05–0.15) (0.04–0.13)
35–40 0.46 0.40 0.34 0.29 0.24 0.19 0.16 0.13 0.10* 0.08*
(0.36–0.57) (0.32–0.49) (0.28–0.41) (0.23–0.35) (0.19–0.29) (0.14–0.25) (0.11–0.22) (0.08–0.19) (0.06–0.17) (0.04–0.15)
40–45 0.50 0.43* 0.37 0.31 0.26 0.22* 0.18 0.14* 0.11 0.09*
(0.39–0.61) (0.34–0.53) (0.29–0.46) (0.25–0.39) (0.20–0.34) (0.15–0.29) (0.12–0.25) (0.09–0.22) (0.06–0.19) (0.05–0.17)
45–50 0.53* 0.48 0.40 0.34 0.29 0.24 0.20 0.16* 0.13 0.10*
(0.41–0.65) (0.36–0.58) (0.31–0.50) (0.26–0.44) (0.21–0.38) (0.17–0.33) (0.13–0.29) (0.09–0.25) (0.07–0.22) (0.05–0.19)
50–55 0.57* 0.50 0.44 0.38 0.32* 0.27* 0.22* 0.18* 0.14* 0.11*
(0.43–0.69) (0.38–0.62) (0.33–0.55) (0.28–0.49) (0.22–0.43) (0.18–0.38) (0.14–0.33) (0.10–0.29) (0.08–0.26) (0.05–0.22)
55–60 0.60* 0.54* 0.47* 0.41* 0.35 0.29* 0.24 0.20* 0.16* 0.13*
(0.45–0.73) (0.40–0.67) (0.34–0.60) (0.29–0.54) (0.24–0.48) (0.19–0.42) (0.15–0.38) (0.11–0.33) (0.08–0.29) (0.06–0.26)
From IVUS-determined post–stent-implantation minimum in-stent area and stent length, one can extrapolate the expected 6-month QCA restenosis rate. The range
of the 2 variables is divided into 10 groups each. The expected restenosis rate for the median of each range was calculated along with the 95% CI for this particular
value (indicated in parentheses).
*There were no actual observations in this range; figures presented are calculated by extrapolation from the model.
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Study Limitations
The study was performed in patients with focal lesions in
relative large coronary vessels. Additional studies are needed
to confirm that our results are also applicable in smaller
vessels or for longer lesions.
Although this study was an analysis of .750 observations,
the majority of these observations were clustered around a
stent length of 15 mm and an in-stent minimum area of
8.0 mm2, and many fewer observations were obtained for
other stent lengths and in-stent cross-sectional areas, so that
refinements may be expected from calculations obtained from
a much larger data bank that includes a wide variety of
in-stent cross-sectional areas and stent lengths.
The inclusion of stent length as a predictor of restenosis
may be confounded by other factors, such as overlap of stent,
implantation of long stents to cover initial long lesion, or long
dissection, all of which may influence restenosis. However,
the inclusion of these observations would more reliably
reflect real-world stenting.
Currently, there is a wide variety of stent types commer-
cially available. Our data are only applicable to the Palmaz-
Schatz, Multi-Link, Radius, and Wallstents. Other stent
designs (for instance, Gianturco-Roubin30) may behave dif-
ferently, and additional studies are needed to confirm the
applicability of our reference chart to other stent types.
Conclusions
We constructed a reference chart that, by use of the IVUS-
determined length of the implanted stent and the minimum
in-stent area, predicted the 6-month QCA restenosis rate.
Thus far, this reference chart is only applicable for stent
implantation in short lesions in relatively large vessels. The
reliability of this reference chart must be confirmed in a
prospective study.
Acknowledgments
We pay tribute to all investigators who were involved in the MUSIC,
WEST-II, and ESSEX registries and ERASER and TRAPIST ran-
domized trials, without whose efforts this study would not have been
possible. We wish to thank the core laboratory technicians and
database managers at Cardialysis Rotterdam. Finally, we thank
Claudia Sprenger de Rover for expert secretarial assistance.
References
1. Fischman DL, Leon MB, Baim DS, Schatz RA, Savage MP, Penn I, Detre
K, Veltri L, Ricci D, Nobuyoshi M, Cleman M, Heuser R, Almond D,
Teirstein PS, Fish D, Colombo A, Brinker J, Moses J, Shaknovich A,
Hirschfeld J, Bailey S, Ellis S, Rake R, Goldberg S. A randomized
comparison of coronary-stent placement and balloon angioplasty in the
treatment of coronary artery disease: Stent Restenosis Study Investi-
gators. N Engl J Med. 1994;331:496–501.
2. Serruys PW, de Jaegere P, Kiemeneij F, Macaya C, Rutsch W, Heyndrickx
G, Emanuelsson H, Marco J, Legrand V, Materne P, Belardi J, Sigwart U,
Colombo A, Goy JJ, van den Heuvel P, Delcan J, Morel MA. A comparison
of balloon-expandable-stent implantation with balloon angioplasty in patients
with coronary artery disease: Benestent Study Group. N Engl J Med. 1994;
331:489–495.
3. Versaci F, Gaspardone A, Tomai F, Crea F, Chiariello L, Gioffre PA. A
comparison of coronary-artery stenting with angioplasty for isolated ste-
nosis of the proximal left anterior descending coronary artery. N Engl
J Med. 1997;336:817–822.
4. Serruys PW, van Hout B, Bonnier H, Legrand V, Garcia E, Macaya C,
Sousa E, van der Giessen W, Colombo A, Seabra-Gomes R, Kiemeneij F,
Ruygrok P, Ormiston J, Emanuelsson H, Fajadet J, Haude M, Klugmann
S, Morel MA. Randomised comparison of implantation of heparin-coated
stents with balloon angioplasty in selected patients with coronary artery
disease (Benestent II). Lancet. 1998;352:673–681.
5. Goldberg SL, Colombo A, Nakamura S, Almagor Y, Maiello L, Tobis
JM. Benefit of intracoronary ultrasound in the deployment of Palmaz-
Schatz stents. J Am Coll Cardiol. 1994;24:996–1003.
6. Mudra H, Klauss V, Blasini R, Kroetz M, Rieber J, Regar E, Theisen K.
Ultrasound guidance of Palmaz-Schatz intracoronary stenting with a
combined intravascular ultrasound balloon catheter. Circulation. 1994;
90:1252–1261.
7. Colombo A, Hall P, Nakamura S, Almagor Y, Maiello L, Martini G,
Gaglione A, Goldberg SL, Tobis JM. Intracoronary stenting without
anticoagulation accomplished with intravascular ultrasound guidance.
Circulation. 1995;91:1676–1688.
8. Dussaillant GR, Mintz GS, Pichard AD, Kent KM, Satler LF, Popma JJ,
Wong SC, Leon MB. Small stent size and intimal hyperplasia contribute
to restenosis: a volumetric intravascular ultrasound analysis. J Am Coll
Cardiol. 1995;26:720–724.
9. Prati F, Di Mario C, Gil R, von Birgelen C, Camenzind E, Montauban van
Swijndregt WJ, de Feyter PJ, Serruys PW, Roelandt JR. Usefulness of
on-line three-dimensional reconstruction of intracoronary ultrasound for
guidance of stent deployment. Am J Cardiol. 1996;77:455–461.
10. Kastrati A, Schomig A, Elezi S, Schuhlen H, Dirschinger J, Hadamitzky
M, Wehinger A, Hausleiter J, Walter H, Neumann FJ. Predictive factors
of restenosis after coronary stent placement. J Am Coll Cardiol. 1997;
30:1428–1436.
11. von Birgelen C, Mintz GS, Nicosia A, Foley DP, van der Giessen WJ,
Bruining N, Airiian SG, Roelandt JR, de Feyter PJ, Serruys PW. Elec-
trocardiogram-gated intravascular ultrasound image acquisition after cor-
onary stent deployment facilitates on-line three-dimensional recon-
struction and automated lumen quantification. J Am Coll Cardiol. 1997;
30:436–443.
12. Stone GW, Hodgson JM, St Goar FG, Frey A, Mudra H, Sheehan H,
Linnemeier TJ. Improved procedural results of coronary angioplasty with
intravascular ultrasound-guided balloon sizing: the CLOUT Pilot Trial:
Clinical Outcomes With Ultrasound Trial (CLOUT) Investigators. Cir-
culation. 1997;95:2044–2052.
13. Savage MP, Fischman DL, Rake R, Leon MB, Schatz RA, Penn I,
Nobuyoshi M, Moses J, Hirshfeld J, Heuser R, Baim D, Cleman M,
Brinker J, Gebhardt S, Goldberg S. Efficacy of coronary stenting versus
balloon angioplasty in small coronary arteries: Stent Restenosis Study
(STRESS) Investigators. J Am Coll Cardiol. 1998;31:307–311.
14. de Jaegere P, Mudra H, Figulla H, Almagor Y, Doucet S, Penn I,
Colombo A, Hamm C, Bartorelli A, Rothman M, Nobuyoshi M,
Yamaguchi T, Voudris V, DiMario C, Makovski S, Hausmann D, Rowe
S, Rabinovich S, Sunamura M, van Es GA. Intravascular ultrasound-
guided optimized stent deployment: immediate and 6 months clinical and
angiographic results from the Multicenter Ultrasound Stenting in Coro-
naries Study (MUSIC study). Eur Heart J. 1998;19:1214–1223.
15. Gorge G, Haude M, Ge J, Voegele E, Gerber T, Rupprecht HJ, Meyer J,
Erbel R. Intravascular ultrasound after low and high inflation pressure
coronary artery stent implantation. J Am Coll Cardiol. 1995;26:725–730.
16. von Birgelen C, Kutryk MJ, Gil R, Ozaki Y, Di Mario C, Roelandt JR, de
Feyter PJ, Serruys PW. Quantification of the minimal luminal cross-
sectional area after coronary stenting by two- and three-dimensional
intravascular ultrasound versus edge detection and videodensitometry.
Am J Cardiol. 1996;78:520–525.
17. von Birgelen C, Gil R, Ruygrok P, Prati F, Di Mario C, van der Giessen
WJ, de Feyter PJ, Serruys PW. Optimized expansion of the Wallstent
compared with the Palmaz-Schatz stent: on-line observations with two-
and three-dimensional intracoronary ultrasound after angiographic
guidance. Am Heart J. 1996;131:1067–1075.
18. Albiero R, Rau T, Schluter M, Di Mario C, Reimers B, Mathey DG, Tobis
JM, Schofer J, Colombo A. Comparison of immediate and
intermediate-term results of intravascular ultrasound versus angiography-
guided Palmaz-Schatz stent implantation in matched lesions. Circulation.
1997;96:2997–3005.
19. Kuntz RE, Gibson CM, Nobuyoshi M, Baim DS. Generalized model of
restenosis after conventional balloon angioplasty, stenting and directional
atherectomy. J Am Coll Cardiol. 1993;21:15–25.
20. Hoffmann R, Mintz GS, Mehran R, Pichard AD, Kent KM, Satler LF,
Popma JJ, Wu H, Leon MB. Intravascular ultrasound predictors of angio-
graphic restenosis in lesions treated with Palmaz-Schatz stents. J Am Coll
Cardiol. 1998;31:43–49.
1782 Circulation October 26, 1999
21. Bauters C, Hubert E, Prat A, Bougrimi K, Van Belle E, McFadden EP,
Amouyel P, Lablanche JM, Bertrand M. Predictors of restenosis after
coronary stent implantation. J Am Coll Cardiol. 1998;31:1291–1298.
22. Serruys PW, van der Giessen WG, and the Investigators for the WEST-II
Study. Clinical and angiographic results with the Multi-Link stent
implanted under intravascular ultrasound guidance (West-2 Study).
J Invas Cardiol. 1998;10(suppl B):20b–27b.
23. Haase J, Escaned J, van Swijndregt EM, Ozaki Y, Gronenschild E, Slager
CJ, Serruys PW. Experimental validation of geometric and densitometric
coronary measurements on the new generation Cardiovascular
Angiography Analysis System (CAAS II). Cathet Cardiovasc Diagn.
1993;30:104–114.
24. Bermejo J, Botas J, Garcia E, Elizaga J, Osende J, Soriano J, Abeytua M,
Delcan JL. Mechanisms of residual lumen stenosis after high-pressure
stent implantation: a quantitative coronary angiography and intravascular
ultrasound study. Circulation. 1998;98:112–118.
25. Hoffmann R, Mintz GS, Dussaillant GR, Popma JJ, Pichard AD, Satler
LF, Kent KM, Griffin J, Leon MB. Patterns and mechanisms of in-stent
restenosis: a serial intravascular ultrasound study. Circulation. 1996;94:
1247–1254.
26. Kasaoka S, Tobis JM, Akiyama T, Reimers B, Di Mario C, Wong ND,
Colombo A. Angiographic and intravascular ultrasound predictors of
in-stent restenosis. J Am Coll Cardiol. 1998;32:1630–1635.
27. Elezi S, Kastrati A, Neumann FJ, Hadamitzky M, Dirschinger J, Schomig
A. Vessel size and long-term outcome after coronary stent placement.
Circulation. 1998;98:1875–1880.
28. Strauss BH, Serruys PW, de Scheerder IK, Tijssen JG, Bertrand ME, Puel
J, Meier B, Kaufmann U, Stauffer JC, Rickards AF, Sigwart U. Relative
risk analysis of angiographic predictors of restenosis within the coronary
Wallstent. Circulation. 1991;84:1636–1643.
29. Foley DP, Melkert R, Serruys PW. Influence of coronary vessel size on
renarrowing process and late angiographic outcome after successful
balloon angioplasty. Circulation. 1994;90:1239–1251.
30. Topol EJ, Serruys PW. Frontiers in interventional cardiology. Circu-
lation. 1998;98:1802–1820.
de Feyter et al IVUS Predictors of In-Stent Restenosis 1783
